Axcentua Pharmaceuticals AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.axcentua.com
AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer
Phase 1
- Conditions
- Adenocarcinoma
- Interventions
- Drug: AXP107-11
- First Posted Date
- 2010-08-16
- Last Posted Date
- 2014-04-23
- Lead Sponsor
- Axcentua Pharmaceuticals AB
- Target Recruit Count
- 44
- Registration Number
- NCT01182246
- Locations
- 🇸🇪
Dept. of Oncology-Pathology, Karolinska University Hospital, Solna, Stockholm, Sweden
🇸🇪Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge, Stockholm, Sweden
© Copyright 2025. All Rights Reserved by MedPath